Intragastric Balloon Treatment Enhances Weight Maintenance Adjunct to Low‐Energy Diet and Group‐Based Cognitive Behavioural Therapy: A Randomized Controlled Trial
Open Access
- 3 June 2026
- journal article
- research article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 28 (8) , 7300-7311
Abstract
Aims: Low‐energy diet (LED) plus cognitive‐behavioural therapy (CBT) produces substantial short‐term weight loss in obesity, but long‐term maintenance remains difficult. We evaluated whether adding intragastric balloon (IGB) treatment to group‐based CBT improves weight maintenance after initial weight loss using LED. Materials and Methods: In this open‐label randomized controlled trial, adults aged 30–65 years with BMI 32.5–45 kg/m 2 underwent a 6‐month run‐in period combining LED and group‐based CBT and were subsequently randomized to CBT and 1‐year IGB or CBT alone. The primary endpoint was weight change in percent between randomization (6 months from enrollment) and 18 months (from enrollment), compared to total body weight (TBW) at enrollment. Secondary outcomes included the proportion of participants achieving weight loss thresholds, metabolic parameters and health‐related quality of life (HRQoL). Results: Of 126 enrolled (mean 43.7 years; BMI 38.0 kg/m 2 ), 107 were randomized 6 months after enrollment (IGB n = 51; CBT n = 56) and lost −18.7% (SE: 0.64) of TBW. At 18 months, the mean weight change from randomization was 5.2% with IGB versus 10.1% with CBT ( p < 0.001). A significantly greater proportion of IGB recipients achieved ≥ 5% (84.3% vs. 63.6%; p = 0.021) and ≥ 10% (70.6% vs. 45.5%; p = 0.013) weight loss after 18 months, compared to the CBT group. Improvements in metabolic parameters and HRQoL showed no between‐group differences. Conclusions: As an adjunct to group‐based CBT and after LED‐induced weight loss, IGB treatment provided a modest advantage in weight maintenance for up to 18 months, although safety concerns remain and long‐term studies are warranted.Keywords
Funding Information
- Region Örebro län (OLL‐886441)
- Region Örebro län (OLL‐935216)
- Region Örebro län (OLL‐939125)
- Region Örebro län (OLL‐964732)
- Region Örebro län (OLL‐970429)
- Region Örebro län (OLL‐983440)
- Nyckelfonden (OLL‐886841)
- Nyckelfonden (OLL‐935201)
- Nyckelfonden (OLL‐973006)
This publication has 45 references indexed in Scilit:
- Predictors of ongoing attendance at an Australian publicly funded specialist obesity serviceObesity Science & Practice, 2024
- Endoscopic therapies for patients with obesity: a systematic review and meta-analysisSurgical Endoscopy, 2023
- Risk and Prophylactic Management of Gallstone Disease in Bariatric Surgery: a Systematic Review and A Bayesian meta-analysisJournal of Gastrointestinal Surgery, 2023
- A Study Examining the Orbera365 Intragastric Balloon Safety and Effects on Weight LossObesity Surgery, 2021
- Effects on body weight, eating behavior, and quality of life of a low‐energy diet combined with behavioral group treatment of persons with class II or III obesity: A 2‐year pilot studyObesity Science & Practice, 2020
- Intragastric Balloon: a Retrospective Evaluation of 5874 Patients on Tolerance, Complications, and Efficacy in Different Degrees of OverweightObesity Surgery, 2020
- The Influence of the Orbera Intragastric Balloon Filling Volumes on Weight Loss, Tolerability, and Adverse Events: a Systematic Review and Meta-AnalysisObesity Surgery, 2017
- Eight‐year weight losses with an intensive lifestyle intervention: The look AHEAD studyObesity, 2013
- Long-term Effects of a Lifestyle Intervention on Weight and Cardiovascular Risk Factors in Individuals With Type 2 Diabetes MellitusArchives of internal medicine (1960), 2010
- Multiple Imputation for Nonresponse in Surveys1987